EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Triarylmethane dyes and Merocyanine 540 for the ex vivo purging of hematopoietic stem cells



Triarylmethane dyes and Merocyanine 540 for the ex vivo purging of hematopoietic stem cells



Proceedings of the American Association for Cancer Research Annual Meeting 43: 650, March




(PDF 0-2 workdays service: $29.90)

Accession: 035985981

Download citation: RISBibTeXText



Related references

Crystal violet combined with Merocyanine 540 for the ex vivo purging of hematopoietic stem cell grafts. Journal of Photochemistry and Photobiology. B, Biology 70(3): 133-144, 2003

The alkyl-lysophospholipid, ET-18-OCH-3 synergistically enhances the merocyanine 540-mediated photoinactivation of leukemia cells: Implications for the extracorporeal purging of autologous hematopoietic stem cells. Bone Marrow Transplantation 19(2): 113-119, 1997

Anti-tumor effect of Merocyanine 540-mediated photochemotherapy combined with Edelfosine: Potential implications for the ex vivo purging of hematopoietic stem cell grafts from breast cancer patients. Journal of Photochemistry & Photobiology B Biology 68(2-3): 101-108, November, 2002

Triarylmethane dyes as therapeutic agents for the photochemical purging of autologous bone marrow grafts from residual tumor cells. Biophysical Journal 78(1 Part 2): 256A, 2000

Effect of hypothermia on the merocyanine 540-mediated purging of hematopoietic cells. Journal of HematoTherapy 6(1): 31-39, 1997

Effect of molecular structure on the performance of triarylmethane dyes as therapeutic agents for photochemical purging of autologous bone marrow grafts from residual tumor cells. Journal of Pharmaceutical Sciences 89(1): 88-99, 2000

Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: Implications for the ex vivo purging of autologous haematopoietic stem cell grafts. Journal of Photochemistry & Photobiology B Biology 69(2): 87-95, February, 2003

Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation. Blood 94(8): 2901-2910, 1999

Comparative effects of amifostine on normal hematopoietic stem cells versus human leukemic cells during ex vivo purging in autologous bone marrow transplants. Seminars in Oncology 21(5 SUPPL 11): 16-20, 1994

Comparative effects of amifostine (Ethyol) on normal hematopoietic stem cells versus human leukemic cells during ex vivo purging in autologous bone marrow transplants. Seminars in Oncology 21(5 Suppl 11): 16-20, 1994

Amifostine protects CD34+ purified stem cells in the merocyanine photolytic purging system. Blood 90(10 SUPPL 1 PART 1): 374A, Nov 15, 1997

Ex vivo purging of leukemia cells using tumor necrosis factor-related apoptosis-inducing ligand in hematopoietic stem cell transplantation. Proceedings of the American Association for Cancer Research Annual Meeting 43: 750-751, March, 2002

Ex vivo purging of leukemia cells using tumor-necrosis-factor-related apoptosis-inducing ligand in hematopoietic stem cell transplantation. Leukemia (Basingstoke) 17(7): 1375-1383, July, 2003

Positive selection of hematopoietic CD34+ stem cells provides 'indirect purging' of CD34- lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins. Bone Marrow Transplantation 13(4): 465-471, 1994

Differential sensitivity of mouse hematopoietic stem cells to merocyanine 540. Differentiation 19(1): 65-67, 1981